A study presented at the European Association for the Study of Diabetes found that patients treated with systemic glucocorticoids are over twice as likely to develop diabetes compared to those not receiving the treatment. Glucocorticoids are commonly used to treat inflammation and autoimmune conditions, causing adverse effects like increased blood sugar levels and diabetes. The study involved over 450,000 adults admitted to a hospital, with patients receiving systemic glucocorticoids being 2.6 times more likely to develop diabetes. These results highlight the importance of monitoring and managing diabetes risk in patients receiving glucocorticoid treatment, as well as the potential for routine clinical data to aid in diabetes management.
Source link
Patients receiving steroids are more than twice as likely to develop diabetes, UK study finds
